The Effect of an Invasive Strategy for Treating Pancreatic Necrosis on Mortality: a Retrospective Multicenter Cohort Study.


Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084

Informations de publication

Date de publication:
09 2020
Historique:
received: 24 01 2019
accepted: 16 07 2019
pubmed: 21 8 2019
medline: 15 4 2021
entrez: 21 8 2019
Statut: ppublish

Résumé

Infected acute necrotic collections (ANC) and walled-off necrosis (WON) of the pancreas are associated with high mortality. The difference in mortality between open necrosectomy and minimally invasive therapies in these patients remains unclear. This retrospective multicenter cohort study was conducted among 44 institutions in Japan from 2009 to 2013. Patients who had undergone invasive treatment for suspected infected ANC/WON were enrolled and classified into open necrosectomy and minimally invasive treatment (laparoscopic, percutaneous, and endoscopic) groups. The association of each treatment with mortality was evaluated and compared. Of 1159 patients with severe acute pancreatitis, 122 with suspected infected ANC or WON underwent the following treatments: open necrosectomy (33) and minimally invasive treatment (89), (laparoscopic three, percutaneous 49, endoscopic 37). Although the open necrosectomy group had a significantly higher mortality on univariate analysis (p = 0.047), multivariate analysis showed no significant associations between open necrosectomy or Charlson index and mortality (p = 0.29, p = 0.19, respectively). However, age (for each additional 10 years, p = 0.012, odds ratio [OR] 1.50, 95% confidence interval [CI] 1.09-2.06) and revised Atlanta criteria-severe (p = 0.001, OR 7.84, 95% CI 2.40-25.6) were significantly associated with mortality. In patients with acute pancreatitis and infected ANC/WON, age and revised Atlanta criteria-severe classification are significantly associated with mortality whereas open necrosectomy is not. The mortality risk for patients undergoing open necrosectomy and minimally invasive treatment does not differ significantly. Although minimally invasive surgery is generally preferred for patients with infected ANC/WON, open necrosectomy may be considered if clinically indicated.

Sections du résumé

BACKGROUND
Infected acute necrotic collections (ANC) and walled-off necrosis (WON) of the pancreas are associated with high mortality. The difference in mortality between open necrosectomy and minimally invasive therapies in these patients remains unclear.
METHODS
This retrospective multicenter cohort study was conducted among 44 institutions in Japan from 2009 to 2013. Patients who had undergone invasive treatment for suspected infected ANC/WON were enrolled and classified into open necrosectomy and minimally invasive treatment (laparoscopic, percutaneous, and endoscopic) groups. The association of each treatment with mortality was evaluated and compared.
RESULTS
Of 1159 patients with severe acute pancreatitis, 122 with suspected infected ANC or WON underwent the following treatments: open necrosectomy (33) and minimally invasive treatment (89), (laparoscopic three, percutaneous 49, endoscopic 37). Although the open necrosectomy group had a significantly higher mortality on univariate analysis (p = 0.047), multivariate analysis showed no significant associations between open necrosectomy or Charlson index and mortality (p = 0.29, p = 0.19, respectively). However, age (for each additional 10 years, p = 0.012, odds ratio [OR] 1.50, 95% confidence interval [CI] 1.09-2.06) and revised Atlanta criteria-severe (p = 0.001, OR 7.84, 95% CI 2.40-25.6) were significantly associated with mortality.
CONCLUSIONS
In patients with acute pancreatitis and infected ANC/WON, age and revised Atlanta criteria-severe classification are significantly associated with mortality whereas open necrosectomy is not. The mortality risk for patients undergoing open necrosectomy and minimally invasive treatment does not differ significantly. Although minimally invasive surgery is generally preferred for patients with infected ANC/WON, open necrosectomy may be considered if clinically indicated.

Identifiants

pubmed: 31428962
doi: 10.1007/s11605-019-04333-7
pii: 10.1007/s11605-019-04333-7
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2037-2045

Références

Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013;144:1252–61.
doi: 10.1053/j.gastro.2013.01.068
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102–11.
doi: 10.1136/gutjnl-2012-302779
Bruno MJ. Improving the Outcome of Acute Pancreatitis. Dig Dis 2016;34:540–5.
doi: 10.1159/000445257
Hackert T, Buchler MW. Decision Making in Necrotizing Pancreatitis. Dig Dis 2016;34:517–24.
doi: 10.1159/000445232
Sarathi Patra P, Das K, Bhattacharyya A, et al. Natural resolution or intervention for fluid collections in acute severe pancreatitis. Br J Surg 2014;101:1721–8.
doi: 10.1002/bjs.9666
Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379–400.
doi: 10.1111/j.1572-0241.2006.00856.x
Bugiantella W, Rondelli F, Boni M, et al. Necrotizing pancreatitis: A review of the interventions. International journal of surgery (London, England) 2016;28 Suppl 1:S163–71.
doi: 10.1016/j.ijsu.2015.12.038
van Santvoort HC, Besselink MG, Bakker OJ, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med 2010;362:1491–502.
doi: 10.1056/NEJMoa0908821
Bakker OJ, van Santvoort HC, van Brunschot S, et al. Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: a randomized trial. Jama 2012;307:1053–61.
doi: 10.1001/jama.2012.276
Isayama H, Nakai Y, Rerknimitr R, et al. Asian consensus statements on endoscopic management of walled-off necrosis. Part 2: Endoscopic management. Journal of gastroenterology and hepatology 2016;31:1555–65.
doi: 10.1111/jgh.13398
Horibe M, Sasaki M, Sanui M, et al. Continuous Regional Arterial Infusion of Protease Inhibitors Has No Efficacy in the Treatment of Severe Acute Pancreatitis: A Retrospective Multicenter Cohort Study. Pancreas 2017;46:510–17.
doi: 10.1097/MPA.0000000000000775
Ikeura T, Horibe M, Sanui M, et al. Validation of the efficacy of the prognostic factor score in the Japanese severity criteria for severe acute pancreatitis: A large multicenter study. United European gastroenterology journal 2017;5:389–97.
doi: 10.1177/2050640616670566
Yang CJ, Chen J, Phillips AR, et al. Predictors of severe and critical acute pancreatitis: a systematic review. Dig. Liver Dis. 2014; 46:446–51.
doi: 10.1016/j.dld.2014.01.158
Mounzer R, Langmead CJ, Wu BU, et al. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology 2012; 142: 1476–82.
doi: 10.1053/j.gastro.2012.03.005
Forsmark CE, Vege SS, Wilcox CM. Acute Pancreatitis. The New England journal of medicine 2016;375:1972–81.
doi: 10.1056/NEJMra1505202
Choi JH, Kim MH, Oh D, et al. Clinical relevance of the revised Atlanta classification focusing on severity stratification system. Pancreatology : official journal of the International Association of Pancreatology (IAP) [et al] 2014;14:324–9.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. International journal of surgery 2014;12:1495–9.
doi: 10.1016/j.ijsu.2014.07.013
Zerem E, Imamovic G, Susic A, Haracic B. Step-up approach to infected necrotising pancreatitis: a 20-year experience of percutaneous drainage in a single centre. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43:478–83.
doi: 10.1016/j.dld.2011.02.020
Tong Z, Li W, Yu W, et al. Percutaneous catheter drainage for infective pancreatic necrosis: is it always the first choice for all patients? Pancreas 2012;41:302–5.
doi: 10.1097/MPA.0b013e318229816f
van Brunschot S, van Grinsven J, van Santvoort HC, et al. Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial. Lancet 2018;391:51–8.
doi: 10.1016/S0140-6736(17)32404-2
IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology : official journal of the International Association of Pancreatology (IAP) [et al] 2013;13:e1–15.
van Brunschot S, Hollemans RA, Bakker OJ, et al. Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients. Gut 2018;67:697–706.
pubmed: 28774886
Besselink MG, Verwer TJ, Schoemaeckers EJ, et al. Timing of surgical intervention in necrotizing pancreatitis. Arch. Surg. 2007; 142: 1194–201.
doi: 10.1001/archsurg.142.12.1194
Bausch D, Wellner U, Kahl S, et al. Minimally invasive operations for acute necrotizing pancreatitis: comparison of minimally invasive retroperitoneal necrosectomy with endoscopic transgastric necrosectomy. Surgery 2012;152:S128–34.
doi: 10.1016/j.surg.2012.05.021
Pascual I, Sabater L, Anon R, et al. Surgical versus nonsurgical treatment of infected pancreatic necrosis: more arguments to change the paradigm. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2013;17:1627–33.
doi: 10.1007/s11605-013-2266-6
van Santvoort HC, Bakker OJ, Bollen TL, et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology 2011;141:1254–63.
doi: 10.1053/j.gastro.2011.06.073

Auteurs

Kazuhiro Minami (K)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.

Masayasu Horibe (M)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
Department of Gastroenterology and Hepatology, Tokyo Metropolitan Tama Medical Center, 2-8-29, Musashidai, Fuchu City, Tokyo, Japan.

Masamitsu Sanui (M)

Department of Anesthesiology and Critical Care Medicine, Division of Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumachou, Omiya-ku, Saitama, Saitama, 330-8503, Japan. msanui@mac.com.

Mitsuhito Sasaki (M)

Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

Eisuke Iwasaki (E)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.

Hirotaka Sawano (H)

Senri Critical Care Medical Center, Osaka Saiseikai Senri Hospital, 1-1-6 Tsukumodai, Suita, Osaka, Japan.

Takashi Goto (T)

Department of Anesthesiology and Intensive Care, Hiroshima City Hiroshima Citizens Hospital, 7-33 Motomachi, Naka-ku, Hiroshima City, Hiroshima, Japan.

Tsukasa Ikeura (T)

Third Department of Internal Medicine, Kansai Medical University, 2-5-1, Shinmachi, Hirakata, Osaka, Japan.

Tsuyoshi Takeda (T)

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Takuya Oda (T)

Department of General Internal Medicine, Iizuka Hospital, 3-83 Yoshiomachi, Iizuka-shi, Fukuoka, Japan.

Hideto Yasuda (H)

Department of Emergency and Critical Care Medicine, Japanese Red Cross Musashino Hospital, 1-26-1 Kyounancho, Musashino City, Tokyo, Japan.

Yuki Ogura (Y)

Department of Gastroenterology and Hepatology, Tokyo Metropolitan Tama Medical Center, 2-8-29, Musashidai, Fuchu City, Tokyo, Japan.

Dai Miyazaki (D)

Advanced Emergency Medical and Critical Care Center, Japanese Red Cross Maebashi Hospital, 3-21-36 Asahi-cho, Maebashi City, Gunma, Japan.

Katsuya Kitamura (K)

Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, Japan.
Department of Gastroenterology and Hepatology, Tokyo Medical University Hachioji Medical Center, 1163 Tatemachi, Hachioji-shi, Tokyo, Japan.

Nobutaka Chiba (N)

Department of Emergency and Critical Care Medicine, Nihon University Hospital, 1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan.

Tetsu Ozaki (T)

Department of Acute care and General Medicine, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Minami-ku, Kumamoto City, Kumamoto, Japan.

Takahiro Yamashita (T)

Emergency Medical Center, Fukuyama City Hospital, 5-23-1 Zao-cho, Fukuyama City, Hiroshima, Japan.
Acute Care Medical Center, Hyogo Prefectural Kakogawa Medical Center, 203 Kanno, Kanno-cho, Kakogawa City, Hyogo, Japan.

Toshitaka Koinuma (T)

Division of Intensive Care, Department of Anesthesiology and Intensive Care Medicine, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi, Japan.

Taku Oshima (T)

Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.

Tomonori Yamamoto (T)

Department of Traumatology and Critical Care Medicine, Osaka City University, 1-4-3 Asahimachi, Abenoku, Osaka City, Osaka, Japan.

Morihisa Hirota (M)

Division of Gastroenterology, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyagino-ku, Sendai, Miyagi, Japan.

Natsuko Tokuhira (N)

Division of Intensive Care Medicine, University Hospital, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, Japan.

Yoshinori Azumi (Y)

Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, Japan.

Keiji Nagata (K)

Department of Critical Care Medicine University Hospital, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahata-nishi-ku, Kitakyushu, Fukuoka, Japan.

Kazunori Takeda (K)

Miyagi Branch Office, Health Insurance Claims Review and Reimbursement Services, 5-1-27, Tsutsujigaoka, Miyagino-ku, Sendai, Miyagi, Japan.

Tomoki Furuya (T)

Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Japan.

Alan Kawarai Lefor (AK)

Department of Surgery, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi, Japan.

Toshihiko Mayumi (T)

Department of Emergency Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahata Nishi, Kitakyushu, Fukuoka, Japan.

Takanori Kanai (T)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH